Tripos Sybyl 7.2 (4 cds and 1 dvd)
<
SYBYL. is a suite of computational informatics software designed to enhance the drug discovery workflows and decision making of todays computational chemists and molecular modelers. An industry standard for over 20 years and the basis for Tripos expert molecular modeling environment, SYBYL provides the fundamental components for understanding molecular structure and properties with an emphasis on the discovery of lead candidates.
Computational chemists understand the impact that continual innovation can bring to the technologies used in their in silico discovery programs. They realize the benefits of complementing their own chemical intuition with validated science. Well designed and frequently updated software can save valuable time and often means the difference between success and failure. Tripos premier computational informatics offering, SYBYL, leads the way in innovation with its ever growing suite of technologies and our commitment to applied science and frequent product enhancements.
Key SYBYL Benefits
Constant and consistent scientific innovation
Comprehensive suite of task based solutions
Fully integrated, easy to use interface
Industry leading Technical Support
Comprehensive Training Workshops
Availability on multiple platforms
This new release includes:
SYBYL 7.2 has been certified to run under RedHat Enterprise Linux 4.0 and IRIX 6.5.26m.
A new SYBYL Quick Reference page is now available in the Tripos Bookshelf. This page is a portal for easy access to definitions and procedures.
The screen capture functionality is available for Linux systems using the ImageMagick Tools.
The Color Editor is available for Linux. It includes a color wheel and the ability for selecting a color or defining a color as RGB or HSL via slider bars.
Cofactors and solvents were added to the biopolymer dictionary.
BUY Tripos Sybyl 7.2 (4 cds and 1 dvd) 30$
TAGS\: buy Tripos Sybyl 7.2 (4 cds and 1 dvd), low cost Tripos Sybyl 7.2 (4 cds and 1 dvd), low price Tripos Sybyl 7.2 (4 cds and 1 dvd)
No comments:
Post a Comment